ARISTADA® (aripiprazole lauroxil) is a long-acting injectable that provides multiple options for dosing strength and dosing interval to help support your efforts to individualize care1These are hypothetical patients living with schizophrenia.
Reference: 1. ARISTADA [package insert]. Waltham, MA: Alkermes, Inc; 2018.
History: Matt has been dealing with schizophrenia for the last couple of years. His primary symptoms have included persistent auditory hallucinations and paranoid delusions. He lives at home with his parents, who, along with his case manager, have brought up the option of long-acting treatment. Matt has previously been on oral medications and tolerates aripiprazole.
"Receiving medication every 2 months allows me not to have to think about it every day."
History: Alex began experiencing auditory hallucinations, paranoid delusions, and social and emotional withdrawal during his freshman year of college.
"I couldn't think straight because of the voices. I couldn't stand it."
He was eventually hospitalized for 5 days, was diagnosed with schizophrenia, and his doctor decided to explore ARISTADA® (aripiprazole lauroxil) as a treatment option while he was in the hospital. After following the full Prescribing Information and dosing instructions, his doctor decided to prescribe the 882-mg dose. The 6-week dosing interval works for him.
History: Lisa had her first psychotic break and was diagnosed with schizophrenia at age 26. Initially she experienced changes in perception, thought process, and thought content. Lisa eventually began experiencing somatic delusions.
"My thoughts were so cluttered that I had a really hard time talking to others. At one point I was convinced that my heart was missing."
Lisa was afraid of seeking treatment when these symptoms began, but she reluctantly agreed to start treatment. She has tried several schizophrenia medications and tolerates aripiprazole. Lisa was started on ARISTADA® (aripiprazole lauroxil) 4 months ago, and she just received her fourth monthly injection.
History: Bill has been on oral antipsychotics for schizophrenia since his initial episode at age 28. He had suffered paranoid delusions of being controlled by the government and that his thoughts were being transmitted to everyone he met by telepathic means. Coworkers noted his blunt affect, passivity, and social withdrawal. After a recent discussion with his nurse practitioner to evaluate alternative treatment options, Bill was started on ARISTADA® (aripiprazole lauroxil).
"I had never heard about a long-acting shot, and when she told me about it, it seemed like it might be worth a try."
History: Maria was diagnosed with schizophrenia 2 months after her divorce, when she presented with visual hallucinations, avolition, apathy, and alogia.
"My friends thought it was all due to the divorce, but then I started seeing all those things that weren’t there."
She then moved in with her mother and has done fairly well living with a caregiver who closely monitors her behavior and her adherence to her oral medication. However, her mother felt that Maria should consider a long-acting option. Maria and her mother recently met with Maria’s physician, who prescribed ARISTADA® (aripiprazole lauroxil).